GlobalData

GlobalData’s report reveals that unmet needs, including underfunding of prevention programs, poor mental health integration,…

GlobalData report highlights rising diagnosed prevalence of multiple sclerosis in the US, with middle-aged adults showing the…

GlobalData’s report captures a moment for the global biopharmaceutical sector, where the pace of innovation is clashing with a…

GlobalData analysts highlight uncertainty around new FDA directives as pharma giants ramp up US-based manufacturing investments…

As current IPF treatments face adoption and efficacy challenges, GlobalData highlights LYT-100’s potential to address unmet needs…

Interim results showed that sibeprenlimab demonstrated a statistically significant and clinically meaningful reduction in 24-hour…

GlobalData’s patient-based forecast highlights that ADCs will see significant sales in the NSCLC space by 2032, led by…

Significant reforms in clinical development processes and regulatory reviews in China have led to faster drug approvals,…

This government-led initiative focuses on developing vaccines against avian influenza that are identified as high-risk candidates…

GlobalData’s latest analysis highlights the results of a retrospective study from Ghent University Hospital based on Belgian…